<DOC>
	<DOC>NCT00743639</DOC>
	<brief_summary>This study describes a controlled randomized clinical trial to evaluate the efficacy of bone marrow derived stem-cell implants by minithoracotomy in patients with dilated cardiomyopathy and cardiac failure class III or NYHA.</brief_summary>
	<brief_title>Autologous Transplantation of Bone Marrow Mononuclear Stem-Cells for Dilated Cardiomyopathy</brief_title>
	<detailed_description />
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Cardiomyopathy, Dilated</mesh_term>
	<criteria>Diagnosis made at more than one year and symptomatic at functional class IIIIV by the New York Heart Association classification (NYHA) despite optimal pharmacologic therapy Left ventricular ejection fraction (LVEF) less than 35% by echocardiogram Age below 70 years Absence of neoplasm Abscence of hematologic disease or systemic disease No previous cardiac intervention Episodes of tachycardia or ventricular fibrillation Severe or moderated mitral insufficiency Any other valvulopathies Previous cardiac surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Cardiomyopathy</keyword>
	<keyword>stem cell</keyword>
	<keyword>cardiac failure</keyword>
</DOC>